GeneFerm Biotechnology Co., Ltd. 1796.TWO Stock
GeneFerm Biotechnology Co., Ltd. Price Chart
GeneFerm Biotechnology Co., Ltd. 1796.TWO Financial and Trading Overview
| GeneFerm Biotechnology Co., Ltd. stock price | 60.6 TWD |
| Previous Close | 113 TWD |
| Open | 114.5 TWD |
| Bid | 110.5 TWD x 0 |
| Ask | 111 TWD x 0 |
| Day's Range | 110.5 - 114.5 TWD |
| 52 Week Range | 40 - 158.5 TWD |
| Volume | 165.12K TWD |
| Avg. Volume | 763.84K TWD |
| Market Cap | 4.58B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 44.55645 |
| EPS (TTM) | 2.99 TWD |
| Forward Dividend & Yield | 1.5 (1.35%) |
| Ex-Dividend Date | June 29, 2023 |
| 1y Target Est | N/A |
1796.TWO Valuation Measures
| Enterprise Value | 4.6B TWD |
| Trailing P/E | 44.55645 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.5145226 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
GeneFerm Biotechnology Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 161.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 158.5 TWD |
| 52 Week Low | 40 TWD |
| 50-Day Moving Average | 126.69 TWD |
| 200-Day Moving Average | 81.53 TWD |
1796.TWO Share Statistics
| Avg. Volume (3 month) | 763.84K TWD |
| Avg. Daily Volume (10-Days) | 512.4K TWD |
| Shares Outstanding | 41.46M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 57.17% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4049 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 15.33 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 222.16M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 2.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 20.038 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of GeneFerm Biotechnology Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Tainan City |
| Address | No.3, Dali 2nd Road |
| ZIP | 741014 |
| Phone | 886 6 510 9001 |
| Website | https://www.geneferm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented health care products in Taiwan and internationally. The company offers microbial fermentation products, which includes nattokinase, red yeast rice, vitamin K2, lactic acid bacteria, etc.; and edible and medicinal mushroom fermentation, functional herbal products, fruit and vegetable fermentation concentrates, and protein products and private label supplements. It also provides microbial fermentation toll manufacturing and technical consulting services. The company was founded in 1988 and is headquartered in Tainan City, Taiwan.
Q&A For GeneFerm Biotechnology Co., Ltd. Stock
What is a current 1796.TWO stock price?
GeneFerm Biotechnology Co., Ltd. 1796.TWO stock price today per share is 60.6 TWD.
How to purchase GeneFerm Biotechnology Co., Ltd. stock?
You can buy 1796.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GeneFerm Biotechnology Co., Ltd.?
The stock symbol or ticker of GeneFerm Biotechnology Co., Ltd. is 1796.TWO.
Which industry does the GeneFerm Biotechnology Co., Ltd. company belong to?
The GeneFerm Biotechnology Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does GeneFerm Biotechnology Co., Ltd. have in circulation?
The max supply of GeneFerm Biotechnology Co., Ltd. shares is 41.46M.
What is GeneFerm Biotechnology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
GeneFerm Biotechnology Co., Ltd. PE Ratio is 20.26755700 now.
What was GeneFerm Biotechnology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
GeneFerm Biotechnology Co., Ltd. EPS is 2.99 TWD over the trailing 12 months.
Which sector does the GeneFerm Biotechnology Co., Ltd. company belong to?
The GeneFerm Biotechnology Co., Ltd. sector is Healthcare.